inclusion criteria: * must be enrolled in the covid19 citizen science (ccs) study. the ccs study is a remote, longitudinal, observational registry hosted on the eureka research platform that administers weekly questionnaires to participants regarding covid-19 symptoms and exposures. ccs is currently open to enrollment for adults aged 18 and older who have a smartphone device to participate on the mobile app, or an email address to participate on the web portal. * must have received either 2 doses of mrna vaccine such as moderna and pfizer, or 1 dose of johnson and johnson

inclusion criteria: * must be enrolled in the covid19 citizen science (ccs) study. the ccs study is a remote, longitudinal, observational registry hosted on the eureka research platform that administers weekly questionnaires to participants regarding covid-19 symptoms and exposures. ccs is currently open to enrollment for adults aged 18 and older who have a smartphone device to participate on the mobile app, or an email address to participate on the web portal. * must have received either 2 doses of mrna vaccine such as moderna and pfizer, or 1 dose of johnson and johnson

inclusion criteria: must be enrolled in the covid19 citizen science (ccs) study. the ccs study is a remote, longitudinal, observational registry hosted on the eureka research platform that administers weekly questionnaires to participants regarding covid-19 symptoms and exposures. ccs is currently open to enrollment for adults aged 18 and older who have a smartphone device to participate on the mobile app, or an email address to participate on the web portal. must have received either 2 doses of mrna vaccine such as moderna and pfizer, or 1 dose of johnson and johnson

inclusion criteria: must be enrolled in the covid19 citizen science (ccs) study. the ccs study is a remote, longitudinal, observational registry hosted on the eureka research platform that administers weekly questionnaires to participants regarding covid-19 symptoms and exposures. ccs is currently open to enrollment for adults aged 18 and older who have a smartphone device to participate on the mobile app, or an email address to participate on the web portal. must have received either 2 doses of mrna vaccine such as moderna and pfizer, or 1 dose of johnson and johnson